Tom Price’s Dubious Trades in Health Care Stocks – New York Times

New York TimesThe law, signed in December, will speed up the Food and Drug Administration’s approval of new medicines. Another lawmaker, Representative Chris Collins of New York, who is a member of the Trump transition team, is Innate’s largest shareholder and is on … and more …read more From:: New York City News By Google […]

from WordPress http://ift.tt/2iI2vEn
via IFTTT